Neurovance Obtains $3,000,003 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e90c0d6c-74c7-42ab-84c8-ceccf5c47d12 - Date
4/1/2014 - Company Name
Neurovance - Mailing Address
43 Thorndike Street Cambridge, MA 02141 USA - Company Description
Neurovance is a stealth pharmaceutical company developing pharmaceutical preparations for the treatment of disorder of the central nervous system. - Website
Undisclosed
- Transaction Type
Venture Equity - Transaction Amount
$3,000,003 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
